Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain
From MaRDI portal
Publication:2171581
DOI10.1016/j.ejor.2021.03.030OpenAlexW3136839507MaRDI QIDQ2171581
Sameer Kumar, Charu Chandra, Priyank Sinha
Publication date: 9 September 2022
Published in: European Journal of Operational Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.ejor.2021.03.030
herd immunityCOVID-19humanitarian logistics (O)lead time disruptionstructural resiliencevaccine supply chain
Related Items
Introduction to the special issue on the role of operational research in future epidemics/ pandemics ⋮ Dynamic planning of a two-dose vaccination campaign with uncertain supplies ⋮ Optimal timing of non-pharmaceutical interventions during an epidemic
Cites Work
- Risk shaping in production planning problem with pricing under random yield
- Computing optimal base-stock levels for an inventory system with imperfect supply
- A disruption recovery plan in a three-stage production-inventory system
- On the calculation of safety stocks when demand is forecasted
- Literature review: the vaccine supply chain
- A stochastic programming model with endogenous and exogenous uncertainty for reliable network design under random disruption
- Measuring and mitigating the effects of cost disturbance propagation in multi-echelon apparel supply chains
- Recovery management for a dial-a-ride system with real-time disruptions
- OR/MS research in disaster operations management
- `Horses for courses' in demand forecasting
- Competition Under Generalized Attraction Models: Applications to Quality Competition Under Yield Uncertainty
- Dynamic re-order point inventory control with lead-time uncertainty: analysis and empirical investigation
- Incremental Cycle Detection, Topological Ordering, and Strong Component Maintenance
- Supply Chain Coordination and Influenza Vaccination
This page was built for publication: Strategies for ensuring required service level for COVID-19 herd immunity in Indian vaccine supply chain
